LXRX Q1 2020 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$693M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M-13.2% YoY

Gross Profit

$7M92.9% margin

Operating Income

-$62M-780.6% margin

Net Income

-$67M-832.7% margin

EPS (Diluted)

$-0.63

QoQ Revenue Growth

-8.3%

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$22M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$371M

Total Liabilities

$316M

Stockholders' Equity

$55M

Cash & Equivalents

$56M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$9M	-13.2%
Gross Profit	$7M	$9M	-14.2%
Operating Income	-$62M	-$17M	-257.4%
Net Income	-$67M	-$22M	-205.6%